In Armstrong Medical Ltd’s efforts to reduce the risks associated with hospital acquired infections, AquaVENT® heated breathing circuits are supplied with BioCote® antimicrobial additive to limit the spread of bacterium species between patients and users, should transferable bacteria come into contact with the surfaces of the breathing circuit.
BioCote® technology in AquaVENT® heated breathing circuits uses inorganic silver ion particles dispersed homogenously throughout the polymer used to form components of the breathing circuit.
On the 9th April 2013 our manufacturing partner BioCote® issued a press release (please click here for a link to the full press release) stating they had commissioned testing of their antimicrobial technology against a carbapenem-resistant Enterobacteria (CRE).
Their independently-performed ISO 22196 test demonstrated elimination of over 99.9% of the bacterium Klebsiella pneumoniae.
BioCote® stated that their technology has already been proven to be effective against a wide range of bacteria and fungi and this brings the total number of multi-drug resistant bacteria which BioCote® technology is known to be effective against to four:
- MRSA (Methicillin-resistant Staphylococcus aureus)
- VRE (Vancomycin-resistant Enterococcus)
- ESBL (Extended Spectrum Beta Lactamase producing E. coli)
- CRE (Carbapenem-resistant Enterobacteriaceae, Klebsiella pneumoniae)
For further information about the diverse range of products that Armstrong Medical Ltd sell please contact Armstrong Medical’s Customer Service team on +44 (0) 28 7035 6029 (Phone lines are open Monday to Friday 9am to 5pm GMT) or email us email@example.com. Alternatively you can visit the BioCote® website for more information.